Table 4.
Cancer-specific standardized incidence ratios (SIRs)
| Cancer site | Aberg 2008 | Baccarani 2010 | Collett 2010 | Ettorre 2013 | Haagsma 2001 | Jiang 2008 | Krynitz 2012 | Serraino 2007 | Kaneko 2013 | Herrero 2010 | Overall SIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Head and neck | 7.63(-14.94-30.20) | 7.0 (3.0-13.7) | 10.45(5.61-15.29) | 4.5 (2.7-7.1) | 2.7 (1.2-5.2) | 2.5 (0.5-7.3) | 1.71(-2.39-5.81) | 5.5 (1.5-14) | 3.7 (0.5-26.6) | 3.46 (1.49-6.82) | 3.836 (2.754–4.918) |
| NHL | 13.9 (6.01-27.4) | 13.8 (6.3–26.2) | 13.3(10.6,16.6) | 7.1 (4.2-11.2) | — | 20.8(14.9-28.3) | 14 (8.9–21) | 16.4 (5.3–38.2) | — | — | 12.174 (10.231– 14.117) |
| Hodgkin lymphoma | 14.7 (0.37-82.0) | — | 8.9(3.8,17.5) | 6.3 (0.8-22.9) | — | — | 0.0 (0.0–27) | — | — | — | 7.027 (1.727–12.328) |
| Leukemia | 0.00 (0.00-41.4) | — | — | — | — | 3.9 (1.0-9.9) | 4.5 (0.5–16) | — | 15.1(4.9-46.9) | — | 4.266 (0.533–8.000) |
| Melanoma of the skin | 2.10 (0.05-11.7) | 4.4 (0.5–16.1) | — | 3.1 (0.9-8.1) | — | — | 1.5 (0.3–4.5) | — | — | — | 2.040 (0.349–3.730) |
| Nonmelanoma | 38.5 (18.5-70.8) | — | 6.6(5.8,7.5) | — | 70.0(28.1-144.2) | — | — | — | 6.4 (1.6-25.4) | — | 6.646 (5.799–7.493) |
| Liver | 0.00 (0.00-28.4) | — | — | 0.8 (0.2-2.3) | — | — | 14 (7.0–27) | 0.0 (0.0–10.9) | — | — | 0.906 (-0.117–1.929) |
| Pancreas | 2.31 (0.06-12.9) | — | — | 1.1 (0.1-3.9) | — | 3.3 (0.7-9.6) | 3.6 (0.7–11) | — | — | — | 1.703 (0.100–3.305) |
| Kidney | 4.17 (0.50-15.1) | — | 1.8(0.8,3.6) | — | 30.0 (6.1-87.7) | 3.1 (0.8-7.9) | 1.9 (0.2–6.9) | — | 6.4 (1.6-25.4) | 3.31(1.51-6.28) | 2.335 (1.270–3.401) |
| Lung, trachea | 0.00 (0.00-3.32) | 1.6 (0.4–4.1) | 1.6(1.2,2.2) | 1.1 (0.6-1.9) | — | 1.4 (0.7-2.6) | 1.8 (0.7–4.0) | 0.5 (0.0–3.1) | — | 2.17(0.99-4.12) | 1.371 (1.043–1.698) |
| Breast | 0.26 (0.01-1.43) | 0.6 (0.0–3.4) | 0.8(0.5,1.1) | 0.7 (0.1-1.9) | — | 0.6 (0.2-1.4) | 1.0 (0.4–2.1) | — | 0.9 (0.1-6.4) | — | 0.719 (0.489–0.949) |
| Prostate | 1.24 (0.15-4.47) | — | — | — | — | 1.0 (0.3-2.4) | 0.5 (0.1–1.2) | — | 2.2 (0.6-8.9) | — | 0.658 (0.186–1.131) |
| Stomach | 4.97 (0.60-18.0) | 3.7 (0.8–10.9) | — | 0.6 (0.1-2.1) | — | — | 3.9 (0.8–11) | — | 1.6 (0.6-4.3) | — | 1.033 (0.182–1.883) |
| Esophagus | — | 23.4 (7.6–54.7) | — | — | — | — | 2.6 (0.1–15) | — | 16.9(2.4-17.9) | 7.91(1.63-23.13) | 9.726 (5.018–14.433) |
| Kaposi’ s sarcoma | — | 144.0(52.9–313.5) | — | 37.3(13.7-81.2) | — | — | 80 (2.0–444) | — | — | — | 44.778 (12.458–77.099) |
| Cervix uteri | — | 30.7 (6.3–89.8) | — | — | — | — | 2.6 (0.1–15) | — | — | — | 3.467 (-3.867–10.801) |
| Thyroid gland | 0.00 (0.00-12.7) | — | 20.0(5.4,51.2) | — | — | — | 0.0 (0.0–14) | — | — | — | 0.809 (-3.798–5.416) |
| All cancer | 0.46 (-1.5–1.07) | 1.81 (0.65–2.975) | 1.6 (1.36–1.84) | 1.13(0.72–1.53) | 2.85 (0.85–4.84) | 1.07(0.62–1.51) | 0.94 (0.52–1.36) | 0.86(-0.59–2.30) | 2.27(0.84–3.70) | 2.76 (1.59–3.93) | 1.319 (1.159–1.478) |
Bold data represent positive results.